M42, a global leader in healthcare, has announced the establishment of a new operating structure aimed at driving innovation and enhancing business growth both locally and internationally. This reorganization will focus on strategic priorities and create a framework for both organic and inorganic growth, including the formation of impactful partnerships and leveraging artificial intelligence to transform traditional healthcare systems.

The new structure includes the creation of four autonomous platforms designed to operate with greater responsibility and accountability. These platforms are expected to fulfill M42’s shared ambitions and support its strategic growth objectives. WAM reports, that the platform, “Global Patient Care,” operates 480 clinics across 26 countries and serves 15 million patients annually. It offers a wide range of services, including Renal Care, Outpatient and Chronic Disease Management, Diagnostics, Women’s & Children’s Health, Specialty Surgery, and Long-Term Care. Dimitris Moulavasilis has been appointed as the Chief Executive Officer of this platform.

The second platform, “Integrated Health Solutions,” will focus on national health programs and population health. Its mission is to address global health disparities through precise, preventive, and predictive care. This platform will encompass several areas, such as Genomics, National Programs, Biobank, Data Services, Environmental Sciences, and clinical research and trials, with Dr. Fahed Al Marzooqi serving as Chief Executive Officer.

Next is the “Digital Health Solutions” platform, which aims to scale digital health innovations and AI-driven solutions to improve patient outcomes and empower healthcare providers. This platform will build upon the successes of initiatives like Malaffi. Kareem Shahin has been appointed as its Chief Executive Officer. Lastly, the “AI Life Sciences” platform will concentrate on drug discovery and development, utilizing AI and partnerships across the life sciences value chain. Dr. Fahed will serve as the Acting CEO until a permanent appointment is made.

Hasan Jasem Al Nowais, the Managing Director and Group Chief Executive Officer at M42, emphasized that the new operating model is a strategic evolution rather than just a structural change. He stated that it is designed to unlock M42’s full potential in the global healthcare landscape. Al Nowais remarked, “Our new structure will empower our platforms and people to seize growth opportunities and expand our footprint, accelerate innovation in healthcare, and revolutionise healthcare systems globally.”